Pioneering three transformative biotechnologies that address critical unmet needs in emergency medicine, chronic disease management, and advanced robotics.
Explore Our TechnologiesThree breakthrough solutions leveraging biocompatible materials, miniaturized life-support systems, and tissue engineering to create life-saving medical innovations.
An implantable or wearable emergency oxygen system that automatically delivers supplemental oxygen when blood oxygen levels drop below safe thresholds.
The ORU stores concentrated oxygen in a biocompatible titanium alloy housing and activates automatically during respiratory crises, providing 16 minutes of life-saving oxygen delivery through an integrated catheter network.
A miniaturized mechanical pump that provides emergency cardiac support during acute heart failure events, maintaining adequate circulation for 30 to 45 minutes.
The system remains dormant during normal cardiac function but activates automatically when sensors detect insufficient cardiac output, providing crucial time for emergency transport and definitive intervention.
Genuine bioengineered human skin with integrated muscle tissue for medical grafting and advanced robotic applications.
Our revolutionary growth-based process produces living human skin that integrates seamlessly for burn victims and trauma patients, while providing authentic biological properties for prosthetic limbs, surgical robots, and humanoid systems.
Addressing substantial markets with accelerating demand driven by aging populations, increasing chronic disease prevalence, and advancing medical technology.
A platform technology company with proven capabilities, established regulatory pathways, and transformative medical solutions.
All three technologies have achieved functional prototype status with successful in vitro testing and early validation studies.
Established FDA approval pathways with experienced regulatory consultants and preliminary agency discussions underway.
Advisory boards and collaborative relationships with leading academic medical centers for clinical validation.
Provisional patents filed covering core aspects of device architecture, manufacturing processes, and control systems.
Hybrid commercialization strategy combining strategic partnerships with major medical device companies and direct manufacturing.
Deep expertise in biomedical engineering, emergency medicine, regulatory affairs, and commercial medical device operations.